Charles W. M. Roberts, MD, PhD, will chair a Monday evening panel discussion on lessons learned from studies of simple genome cancers.

Monday forums will cover topics including financial hardship in cancer care; treatment and research capabilities in low-resource settings; new weight-loss drugs and the obesity-cancer axis; and optimizing cancer vaccines.

Annual Meeting Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, preview notable items on Sunday’s schedule to help you plan your day.

American Society of Clinical Oncology (ASCO) President Lynn M. Schuchter, MD, and AACR President Philip D. Greenberg, MD, FAACR, will chair a special session on strategies for detecting minimal residual disease and how to apply it in the clinic.

Annual Meeting attendees will have the chance to hear individual presentations from Lillian L. Siu, MD, FAACR; Jennifer Rubin Grandis, MD, FAACR; Sangeeta N. Bhatia, MD, PhD, FAACR; Kenneth C. Anderson, MD, FAACR; and Gerrit A. Meijer, MD, PhD.

Tatsuhiro Shibata, MD, PhD, and Elena Elimova, MD, MSc, will chair a special session featuring an international panel of experts discussing novel molecular drivers of gastroesophageal cancers and evolving biomarker driven therapies.

Moran Amit, MD, PhD, will chair a Sunday symposium on how the nervous system regulates cancer and how cancer neuroimmunology may transform clinical oncology.

Massimo Cristofanilli, MD, will chair a Sunday afternoon panel discussion on recent research into diagnostic and treatment strategies for inflammatory breast cancer.

W. Kimryn Rathmell, MD, PhD, will share updates on her first months as director of the National Cancer Institute and continued progress on President Joe Biden’s Cancer Moonshot initiative during two different sessions at the Annual Meeting.

Annual Meeting Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, preview notable items on Saturday’s schedule to help you plan your day.